Actively Recruiting
Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729)
Led by Arbutus Biopharma Corporation · Updated on 2024-11-27
50
Participants Needed
18
Research Sites
276 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a long term follow-up study for chronic hepatitis B (CHB) subjects who have received imdusiran treatment in a prior clinical trial, stopped NA therapy during that trial, and remain off therapy. Subjects may enroll after completing the end of study visit (baseline visit within 12 weeks ± 1 week from the end of study \[EOS\] visit) from their imdusiran clinical trial (the "parent study"). No interventions will be performed in this study other than blood sample collections, review of current medications, and reporting of any adverse events related to study procedures or NA therapy if restarted. Study participation will be for approximately 2 years (to complete a total of at least 3 years of follow-up while off NA therapy, inclusive of parent study participation).
CONDITIONS
Official Title
Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Have participated in a prior imdusiran clinical trial
- Have discontinued NA therapy in that trial and remain off NA therapy
- Have completed less than 3 years of follow-up visits after NA discontinuation in the parent study
- Have the ability to review and provide signed informed consent which includes compliance with all protocol-specified visit schedules and requirements
You will not qualify if you...
- Not applicable
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 18 locations
1
Research and Education Inc.
San Diego, California, United States, 92105
Actively Recruiting
2
University of Miami Miller School of Medicine
Miami, Florida, United States, 33136
Not Yet Recruiting
3
Infectious Disease Care
Hillsborough, New Jersey, United States, 08844
Actively Recruiting
4
The Alfred Hospital
Melbourne, Victoria, Australia, 3004
Actively Recruiting
5
Fiona Stanley Hospital
Murdoch, Australia, 6150
Not Yet Recruiting
6
Prince of Wales Hospital
Shatin, New Territories, Hong Kong
Actively Recruiting
7
Queen Mary Hospital
Hong Kong, Hong Kong
Actively Recruiting
8
Arensia Exploratory Medicine Moldova
Chisinau, Moldova
Actively Recruiting
9
Asan Medial Center
Seoul, South Korea, 05505
Not Yet Recruiting
10
Changhua Christian Hospital
Changhua, Taiwan, 600566
Actively Recruiting
11
Chia-Yi Christian Hospital
Chiayi City, Taiwan, 60002
Actively Recruiting
12
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan, 80756
Actively Recruiting
13
E-Da Hospital
Kaohsiung City, Taiwan, 82445
Actively Recruiting
14
Taichung Veterans General Hospital
Taichung, Taiwan, 40705
Actively Recruiting
15
Chang Gung Medical Foundation Linkou
Taoyuan, Taiwan, 33305
Actively Recruiting
16
University Hospital of Wales, Cardiff
Cardiff, United Kingdom, CF144XW
Not Yet Recruiting
17
Royal London Hospital
London, United Kingdom, E11FR
Not Yet Recruiting
18
King's College Hospital
London, United Kingdom, SE59RS
Not Yet Recruiting
Research Team
M
Michael Child
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here